Investigation Overview
San Diego, Oct. 21, 2011 (Shareholders Foundation) -- Rumors about a potential sale of Holliston, Massachusetts-based Harvard Bioscience have prompted an investigation on behalf of investors of Harvard Bioscience, Inc. (NASDAQ:HBIO) over possible breaches of fiduciary duties. The investigation by a law firm is at an early stage and monitors the situation. It concerns whether Harvard ...
You must register (for free) or login to view the entire investigation.